|
Summary Information: Cue Biopharma Inc. Common Stock NASDAQ:CUE |
  admin@troach.net |
Our Main Pages Stocks.TRoach.Net TRoach.Org TRoach.Net |
_Description: Cue Biopharma, a clinical-stage biopharmaceutical company, is engineering a novel class of injectable biologics to selectively engage and modulate targeted T cells directly within the patient's body to transform the treatment of cancer, infectious diseases and autoimmune diseases. The company's proprietary platform, Immuno-STAT ™(Selective Targeting and Alteration of T cells) is designed to harness the body's intrinsic immune system without the need for ex vivo manipulation.
__The following are links to various summary and news pages for __Cue Biopharma Inc. Common Stock [ CUE ]. __Note: Some Links might not have information for the company. |
|